Geron REACH4RYTELO Patient Support Program
The Geron REACH4RYTELO Patient Support Program can help your eligible patients who have been prescribed Rytelo navigate access and affordability.
Patient Support Program | RYTELOHCP
Drugs
Indications
Patient support programs
Drug
Rytelo (imetelstat)
Indications
Treatment of adult patients with low- to
intermediate-1-risk myelodysplastic
syndromes with transfusion-dependent
anemia requiring ≥4 red blood cell units
over 8 weeks who have not responded to
or have lost response to or are ineligible for
erythropoiesis-stimulating agents
Patient support programs